{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:40:47Z","timestamp":1793324447058,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejphar.2024.176998","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T06:20:59Z","timestamp":1726122059000},"page":"176998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Sodium butyrate alleviates lipopolysaccharide-induced inflammation through JAK\/STAT signalling in primary human corneal fibroblasts"],"prefix":"10.1016","volume":"983","author":[{"given":"Hui-Fang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ran","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Kui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejphar.2024.176998_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176998_bib2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/ijms18030562","article-title":"Inhibition of NLRP3 inflammasome pathway by butyrate improves corneal wound healing in corneal alkali burn","volume":"18","author":"Bian","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176998_bib3","doi-asserted-by":"crossref","DOI":"10.4110\/in.2020.20.e15","article-title":"The role of butyrate in attenuating pathobiont-induced hyperinflammation","volume":"20","author":"Chen","year":"2020","journal-title":"Immune network"},{"issue":"5","key":"10.1016\/j.ejphar.2024.176998_bib4","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/nu11051026","article-title":"Effects of intestinal Microbial\u207bElaborated butyrate on oncogenic signaling pathways","volume":"11","author":"Chen","year":"2019","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.ejphar.2024.176998_bib5","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1021\/acsbiomaterials.0c00510","article-title":"Regulation of keratocyte phenotype and cell behavior by substrate stiffness","volume":"6","author":"Chen","year":"2020","journal-title":"ACS biomaterials science & engineering"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176998_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00905-16","article-title":"MUC2 mucin and butyrate contribute to the synthesis of the antimicrobial peptide cathelicidin in response to entamoeba histolytica- and dextran sodium sulfate-induced colitis","volume":"85","author":"Cobo","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejphar.2024.176998_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100804","article-title":"Contact lens-related corneal infection: intrinsic resistance and its compromise","volume":"76","author":"Fleiszig","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"issue":"9","key":"10.1016\/j.ejphar.2024.176998_bib8","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.04-1365","article-title":"Potentiation of lipopolysaccharide-induced chemokine and adhesion molecule expression in corneal fibroblasts by soluble CD14 or LPS-binding protein","volume":"46","author":"Fukuda","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.ejphar.2024.176998_bib9","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3390\/ijms18091831","article-title":"Corneal fibroblasts as sentinel cells and local immune modulators in infectious keratitis","volume":"18","author":"Fukuda","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176998_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108229","article-title":"Corneal fibroblasts: function and markers","volume":"200","author":"Fukuda","year":"2020","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176998_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.61.3.8","article-title":"The potential inhibitory effects of miR-19b on ocular inflammation are mediated upstream of the JAK\/STAT pathway in a murine model of allergic conjunctivitis","volume":"61","author":"Guo","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176998_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"4\u20135","key":"10.1016\/j.ejphar.2024.176998_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1025396316169","article-title":"Roles of lumican and keratocan on corneal transparency","volume":"19","author":"Kao","year":"2002","journal-title":"Glycoconj. J."},{"issue":"7","key":"10.1016\/j.ejphar.2024.176998_bib14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/ICO.0000000000001206","article-title":"A pilot randomized trial on safety and efficacy of a novel topical combined inhibitor of Janus kinase 1\/3 and spleen tyrosine kinase for GVHD-associated ocular surface disease","volume":"36","author":"Kheirkhah","year":"2017","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176998_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.exer.2011.10.015","article-title":"Identification of common secreted factors in human corneal fibroblasts exposed to LPS, poly(I:C), or zymosan","volume":"96","author":"Kimura","year":"2012","journal-title":"Exp. Eye Res."},{"issue":"24","key":"10.1016\/j.ejphar.2024.176998_bib16","doi-asserted-by":"crossref","first-page":"21672","DOI":"10.1074\/jbc.M301169200","article-title":"Keratocan-deficient mice display alterations in corneal structure","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ejphar.2024.176998_bib17","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41433-020-01333-9","article-title":"Calculating the economic burden of presumed microbial keratitis admissions at a tertiary referral centre in the UK","volume":"35","author":"Moussa","year":"2021","journal-title":"Eye (Lond)."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176998_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s13668-023-00461-4","article-title":"Butyrate: more than a short chain fatty acid","volume":"12","author":"Mohamed Elfadil","year":"2023","journal-title":"Current nutrition reports"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176998_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/ICU.0000000000000273","article-title":"Use of adjunctive topical corticosteroids in bacterial keratitis","volume":"27","author":"Ni","year":"2016","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"16","key":"10.1016\/j.ejphar.2024.176998_bib20","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.3390\/ijms22168979","article-title":"Pivotal role of corneal fibroblasts in progression to corneal ulcer in bacterial keratitis","volume":"22","author":"Nishida","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ejphar.2024.176998_bib21","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1167\/iovs.19-26928","article-title":"Therapeutic effects of STAT3 inhibition on experimental murine dry eye","volume":"60","author":"Qu","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176998_bib22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/bjophthalmol-2021-320077","article-title":"Population-based study on the prevalence, clinical characteristics and vision-related quality of life in patients with corneal opacity resulting from infectious keratitis: results from the Corneal Opacity Rural Epidemiological study","volume":"107","author":"Raj","year":"2023","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176998_bib23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.semarthrit.2019.06.004","article-title":"New observations and emerging ideas in diagnosis and management of non-infectious uveitis: a review","volume":"49","author":"Rosenbaum","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.ejphar.2024.176998_bib24","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1167\/iovs.19-27306","article-title":"Inhibition by epigallocatechin gallate of IL-1-induced urokinase-type plasminogen activator expression and collagen degradation by corneal fibroblasts","volume":"60","author":"Sugioka","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2024.176998_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.exer.2014.09.012","article-title":"The corneal fibrosis response to epithelial-stromal injury","volume":"142","author":"Torricelli","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejphar.2024.176998_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101031","article-title":"Bacterial keratitis: identifying the areas of clinical uncertainty","volume":"89","author":"Tuft","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"issue":"10","key":"10.1016\/j.ejphar.2024.176998_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13498","article-title":"Butyrate to combat obesity and obesity-associated metabolic disorders: current status and future implications for therapeutic use","volume":"23","author":"van Deuren","year":"2022","journal-title":"Obes. Rev.: an official journal of the International Association for the Study of Obesity"},{"issue":"11","key":"10.1016\/j.ejphar.2024.176998_bib28","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/02713683.2020.1748658","article-title":"P38 inhibition prevents herpes simplex virus type 1 (HSV-1) infection in cultured corneal keratocytes","volume":"45","author":"Xian-Kui","year":"2020","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejphar.2024.176998_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108062","article-title":"Keratocyte biology","volume":"196","author":"Yam","year":"2020","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176998_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1167\/tvst.11.3.34","article-title":"Topical administration of 0.3% tofacitinib suppresses M1 macrophage polarization and allograft corneal rejection by blocking STAT1 activation in the rat cornea","volume":"11","author":"Yu","year":"2022","journal-title":"Translational vision science & technology"},{"key":"10.1016\/j.ejphar.2024.176998_bib31","first-page":"2556","article-title":"Histone deacetylase inhibitors blocked activation and caused senescence of corneal stromal cells","volume":"14","author":"Zhou","year":"2008","journal-title":"Mol. Vis."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924006885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924006885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T04:51:29Z","timestamp":1730436689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924006885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"alternative-id":["S0014299924006885"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176998","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium butyrate alleviates lipopolysaccharide-induced inflammation through JAK\/STAT signalling in primary human corneal fibroblasts","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"176998"}}